Clinical Trials Directory

Trials / Completed

CompletedNCT05275270

Role of Topical Oxytocin Gel in Post-Menopausal Women

Role of Topical Oxytocin Gel On Vaginal Atrophy, Psycho-sexual and Psychological Function and Metabolic and Inflammatory Parameters in Post-Menopausal Egyptian Women

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Al-Azhar University · Academic / Other
Sex
Female
Age
47 Years – 66 Years
Healthy volunteers
Accepted

Summary

Aim of the current study: To evaluate the effect of a14 day treatment period with local intravaginal application of an oxytocin-containing gel on vaginal atrophy, psychosexual and psychological/cognitive function, and metabolic, stress, and inflammatory parameters in Egyptian post-menopausal women

Conditions

Interventions

TypeNameDescription
OTHERoxytocin gelThe active oxytocin gel (A) consisted of oxytocin dissolved in a gel-based on hypromellose with a pH of 3.8. 1 ml of gel contained 600 IU of oxytocin
OTHERplacebo gelThe placebo gel (B) consisted of the gel alone

Timeline

Start date
2020-12-01
Primary completion
2021-05-31
Completion
2021-05-31
First posted
2022-03-11
Last updated
2022-03-11

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05275270. Inclusion in this directory is not an endorsement.